Q2 wraps up with more than $6 2 billion in digital health investments mobihealthnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from mobihealthnews.com Daily Mail and Mail on Sunday newspapers.
Photo by Kwanchai Lerttanapunyaporn/Getty Images
Glytec, an insulin management software company, has received $21 million in funding from Silicon Valley Bank, Savitr Capital and other private investors.
The company collected $9 million in debt financing from SVB and $12 million in equity investments led by Savitr positions, according to its announcement.
WHAT IT DOES
Glytec’s eGlycemic Management System is centered on its FDA-cleared Glucommander algorithm. The algorithm uses real-time and historical patient data to personalize insulin dosing by learning each patient’s insulin sensitivity and estimating future needs.
In addition to the personalized insulin dosing, the eGMS dashboard for providers includes glycemic management analytics, continuous surveillance of blood glucose levels and automated reminders for blood glucose checks.
Apple displays airport travel guidance, Facebook adds vaccine themed frame and other digital health briefs mobihealthnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from mobihealthnews.com Daily Mail and Mail on Sunday newspapers.